InsidersTradesSigma
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
Discover the full record of transactions filed by Halkuff Dawn, 董事. Officer active across 1 company, notably Xeris Biopharma Holdings, Inc.. In total, 6 filings have been logged. Breakdown: 1 buy · 1 sell. Total volume traded: €274k. History available since 8 June 2022. The latest transaction was filed on 12 August 2025 (Cession). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 条申报中的 6 条
Dawn Halkuff is a Director at Xeris Biopharma Holdings, Inc. She plays a vital role in corporate governance and strategic decision-making. As a board member, she helps guide Xeris Biopharma's growth initiatives. Her experience in the biopharmaceutical sector is an asset for the company.